Company overview unavailable
$94.17
+$1.07 (+1.15%)Last close · 2026-09-04
Free AI rating for MDT
See QuantAdvisor's buy/sell/hold call and the reasoning — no account needed.
Price history
Daily closing prices for MDT.
+$13.48 (+16.71%) over the last 3m
Related news
Recent coverage of MDT.

Medtronic (MDT) shows strong technical breakout setup with 8/10 rating and tight consolidation. See key levels, moving averages, and trade idea.
ChartMill · 1d ago

While two high-profile segments - WATCHMAN and Electrophysiology - have stumbled, the market is overlooking the company's core stability. Business units representing roughly 75% of revenue are performing consistently with their historical track record, though this durable base's near-term ~6% growth leaves our 10.8% three-year CAGR reliant on a post-2026 pipeline re-acceleration.
Yahoo · 1d ago

Johnson & Johnson (JNJ) stock returned 59.9% over the past year, against 21.1% for the S&P 500. The company has a clean story for it. The biosimilar hit it had been bracing for arrived and was absorbed, and its talc litigation now has a proposed ending. Both are real. The first does not explain a move that size, and the second is not finished.
Yahoo · 2d ago

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences:
Yahoo · 2d ago

BSX's ICVT sales have jumped 15% as coronary therapies gained traction, while new devices and deals could extend its growth momentum.
Yahoo · 2d ago

The medical device maker is on the cusp of a multi-year recovery.
Yahoo · 3d ago

Check out our earnings calendar for this week, as well as our previews and recaps of the more noteworthy reports.
Yahoo · 3d ago

Johnson & Johnson (JNJ) has had a good year. The stock is up 56.5% over the past twelve months against 19.1% for the S&P 500, and at $271.19 sits at about 99% of its 52-week high. The business is still growing. The risk is that the current stock price discounts an acceleration well ahead of management's near-term guidance.
Yahoo · 3d ago
Key statistics
Company fundamentals are temporarily unavailable.
StockTwits chatter
What traders are saying on StockTwits right now
No StockTwits chatter available right now.
Source: StockTwits
Community
Recent posts mentioning MDT.
Sign in to join the QuantAdvisor conversation on MDT — post your take, like and follow.
Data may be delayed. For research, not financial advice.
© 2026 QuantAdvisor. All rights reserved.